Rapport Therapeutics, Inc. RAPP Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Rapport Therapeutics, Inc. (RAPP) reported operating lease right-of-use assets in other assets of $9.33M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Rapport Therapeutics, Inc.'s operating lease right-of-use assets in other assets increased by 24.9% year-over-year, from $7.47M to $9.33M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 118.1% compound annual growth rate (CAGR), from $2.08M to $9.91M.